(RCL) Royal Caribbean Cruises - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: LR0008862868
Stock: Cruises, Voyages, Expeditions, Ships, Itineraries
Total Rating 47
Risk 56
Buy Signal -1.15
| Risk 5d forecast | |
|---|---|
| Volatility | 50.9% |
| Relative Tail Risk | -10.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.67 |
| Alpha | -6.78 |
| Character TTM | |
|---|---|
| Beta | 1.593 |
| Beta Downside | 1.857 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.02% |
| CAGR/Max DD | 1.72 |
EPS (Earnings per Share)
Revenue
Description: RCL Royal Caribbean Cruises March 01, 2026
Royal Caribbean Cruises Ltd. (NYSE:RCL) is a global cruise operator that runs the Royal Caribbean International, Celebrity Cruises, and Silversea Cruises brands, managing a fleet of 69 vessels as of December 31 2025.
Recent performance highlights include FY 2024 revenue of $7.3 billion, an adjusted EBITDA of $1.5 billion, and an average occupancy rate of 95% across its fleet, while the company’s cash balance stood at $5.2 billion with net debt of $9.5 billion.
Key drivers for the cruise sector remain strong discretionary-spending trends-U.S. consumer confidence rose to 115 in Q4 2025-and moderated fuel costs, as Brent crude averaged $78 per barrel, supporting operating margins.
For a deeper dive into RCL’s valuation metrics, you might explore the analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 4.27b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -2.42 > 1.0 |
| NWC/Revenue: -54.89% < 20% (prev -49.21%; Δ -5.68% < -1%) |
| CFO/TA 0.16 > 3% & CFO 6.46b > Net Income 4.27b |
| Net Debt (21.81b) to EBITDA (6.91b): 3.16 < 3 |
| Current Ratio: 0.18 > 1.5 & < 3 |
| Outstanding Shares: last quarter (273.0m) vs 12m ago -1.44% < -2% |
| Gross Margin: 46.84% > 18% (prev 0.48%; Δ 4636 % > 0.5%) |
| Asset Turnover: 45.58% > 50% (prev 44.47%; Δ 1.11% > 0%) |
| Interest Coverage Ratio: 5.34 > 6 (EBITDA TTM 6.91b / Interest Expense TTM 992.0m) |
Altman Z'' 0.00
| A: -0.24 (Total Current Assets 2.21b - Total Current Liabilities 12.05b) / Total Assets 41.62b |
| B: 0.14 (Retained Earnings 5.92b / Total Assets 41.62b) |
| C: 0.13 (EBIT TTM 5.30b / Avg Total Assets 39.34b) |
| D: 0.17 (Book Value of Equity 5.32b / Total Liabilities 31.37b) |
| Altman-Z'' Score: -0.00 = B |
Beneish M -3.20
| DSRI: 0.79 (Receivables 317.0m/371.0m, Revenue 17.93b/16.48b) |
| GMI: 1.01 (GM 46.84% / 47.52%) |
| AQI: 0.96 (AQ_t 0.07 / AQ_t-1 0.08) |
| SGI: 1.09 (Revenue 17.93b / 16.48b) |
| TATA: -0.05 (NI 4.27b - CFO 6.46b) / TA 41.62b) |
| Beneish M-Score: -3.20 (Cap -4..+1) = AA |
What is the price of RCL shares?
As of March 06, 2026, the stock is trading at USD 287.21 with a total of 2,067,241 shares traded.
Over the past week, the price has changed by -8.24%, over one month by -12.61%, over three months by +11.15% and over the past year by +28.14%.
Over the past week, the price has changed by -8.24%, over one month by -12.61%, over three months by +11.15% and over the past year by +28.14%.
Is RCL a buy, sell or hold?
Royal Caribbean Cruises has received a consensus analysts rating of 4.33.
Therefore, it is recommended to buy RCL.
- StrongBuy: 15
- Buy: 6
- Hold: 6
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the RCL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 363.5 | 26.6% |
| Analysts Target Price | 363.5 | 26.6% |
RCL Fundamental Data Overview March 06, 2026
P/E Trailing = 19.9333
P/E Forward = 17.762
P/S = 4.7283
P/B = 8.5964
P/EG = 1.345
Revenue TTM = 17.93b USD
EBIT TTM = 5.30b USD
EBITDA TTM = 6.91b USD
Long Term Debt = 18.16b USD (from longTermDebt, last quarter)
Short Term Debt = 3.27b USD (from shortTermDebt, last quarter)
Debt = 22.64b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 21.81b USD (from netDebt column, last quarter)
Enterprise Value = 106.61b USD (84.80b + Debt 22.64b - CCE 825.0m)
Interest Coverage Ratio = 5.34 (Ebit TTM 5.30b / Interest Expense TTM 992.0m)
EV/FCF = 86.26x (Enterprise Value 106.61b / FCF TTM 1.24b)
FCF Yield = 1.16% (FCF TTM 1.24b / Enterprise Value 106.61b)
FCF Margin = 6.89% (FCF TTM 1.24b / Revenue TTM 17.93b)
Net Margin = 23.82% (Net Income TTM 4.27b / Revenue TTM 17.93b)
Gross Margin = 46.84% ((Revenue TTM 17.93b - Cost of Revenue TTM 9.54b) / Revenue TTM)
Gross Margin QoQ = 36.72% (prev 51.76%)
Tobins Q-Ratio = 2.56 (Enterprise Value 106.61b / Total Assets 41.62b)
Interest Expense / Debt = 1.18% (Interest Expense 267.0m / Debt 22.64b)
Taxrate = 1.93% (15.0m / 777.0m)
NOPAT = 5.19b (EBIT 5.30b * (1 - 1.93%))
Current Ratio = 0.18 (Total Current Assets 2.21b / Total Current Liabilities 12.05b)
Debt / Equity = 2.26 (Debt 22.64b / totalStockholderEquity, last quarter 10.04b)
Debt / EBITDA = 3.16 (Net Debt 21.81b / EBITDA 6.91b)
Debt / FCF = 17.65 (Net Debt 21.81b / FCF TTM 1.24b)
Total Stockholder Equity = 9.31b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.86% (Net Income 4.27b / Total Assets 41.62b)
RoE = 45.87% (Net Income TTM 4.27b / Total Stockholder Equity 9.31b)
RoCE = 19.27% (EBIT 5.30b / Capital Employed (Equity 9.31b + L.T.Debt 18.16b))
RoIC = 17.71% (NOPAT 5.19b / Invested Capital 29.32b)
WACC = 9.55% (E(84.80b)/V(107.44b) * Re(11.79%) + D(22.64b)/V(107.44b) * Rd(1.18%) * (1-Tc(0.02)))
Discount Rate = 11.79% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.26%
[DCF] Terminal Value 63.55% ; FCFF base≈1.54b ; Y1≈1.01b ; Y5≈461.4m
[DCF] Fair Price = N/A (negative equity: EV 7.12b - Net Debt 21.81b = -14.69b; debt exceeds intrinsic value)
EPS Correlation: 83.42 | EPS CAGR: 151.5% | SUE: 0.07 | # QB: 0
Revenue Correlation: 78.62 | Revenue CAGR: 44.93% | SUE: -0.45 | # QB: 0
EPS next Quarter (2026-06-30): EPS=4.46 | Chg7d=-0.035 | Chg30d=-0.304 | Revisions Net=-11 | Analysts=19
EPS current Year (2026-12-31): EPS=18.11 | Chg7d=+0.108 | Chg30d=+0.380 | Revisions Net=+21 | Growth EPS=+15.8% | Growth Revenue=+10.2%
EPS next Year (2027-12-31): EPS=20.73 | Chg7d=+0.116 | Chg30d=+0.361 | Revisions Net=+10 | Growth EPS=+14.4% | Growth Revenue=+7.4%
[Analyst] Revisions Ratio: -1.00 (0 Up / 11 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.8% (Discount Rate 11.8% - Earnings Yield 5.0%)
[Growth] Growth Spread = +0.9% (Analyst 7.7% - Implied 6.8%)
P/E Forward = 17.762
P/S = 4.7283
P/B = 8.5964
P/EG = 1.345
Revenue TTM = 17.93b USD
EBIT TTM = 5.30b USD
EBITDA TTM = 6.91b USD
Long Term Debt = 18.16b USD (from longTermDebt, last quarter)
Short Term Debt = 3.27b USD (from shortTermDebt, last quarter)
Debt = 22.64b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 21.81b USD (from netDebt column, last quarter)
Enterprise Value = 106.61b USD (84.80b + Debt 22.64b - CCE 825.0m)
Interest Coverage Ratio = 5.34 (Ebit TTM 5.30b / Interest Expense TTM 992.0m)
EV/FCF = 86.26x (Enterprise Value 106.61b / FCF TTM 1.24b)
FCF Yield = 1.16% (FCF TTM 1.24b / Enterprise Value 106.61b)
FCF Margin = 6.89% (FCF TTM 1.24b / Revenue TTM 17.93b)
Net Margin = 23.82% (Net Income TTM 4.27b / Revenue TTM 17.93b)
Gross Margin = 46.84% ((Revenue TTM 17.93b - Cost of Revenue TTM 9.54b) / Revenue TTM)
Gross Margin QoQ = 36.72% (prev 51.76%)
Tobins Q-Ratio = 2.56 (Enterprise Value 106.61b / Total Assets 41.62b)
Interest Expense / Debt = 1.18% (Interest Expense 267.0m / Debt 22.64b)
Taxrate = 1.93% (15.0m / 777.0m)
NOPAT = 5.19b (EBIT 5.30b * (1 - 1.93%))
Current Ratio = 0.18 (Total Current Assets 2.21b / Total Current Liabilities 12.05b)
Debt / Equity = 2.26 (Debt 22.64b / totalStockholderEquity, last quarter 10.04b)
Debt / EBITDA = 3.16 (Net Debt 21.81b / EBITDA 6.91b)
Debt / FCF = 17.65 (Net Debt 21.81b / FCF TTM 1.24b)
Total Stockholder Equity = 9.31b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.86% (Net Income 4.27b / Total Assets 41.62b)
RoE = 45.87% (Net Income TTM 4.27b / Total Stockholder Equity 9.31b)
RoCE = 19.27% (EBIT 5.30b / Capital Employed (Equity 9.31b + L.T.Debt 18.16b))
RoIC = 17.71% (NOPAT 5.19b / Invested Capital 29.32b)
WACC = 9.55% (E(84.80b)/V(107.44b) * Re(11.79%) + D(22.64b)/V(107.44b) * Rd(1.18%) * (1-Tc(0.02)))
Discount Rate = 11.79% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.26%
[DCF] Terminal Value 63.55% ; FCFF base≈1.54b ; Y1≈1.01b ; Y5≈461.4m
[DCF] Fair Price = N/A (negative equity: EV 7.12b - Net Debt 21.81b = -14.69b; debt exceeds intrinsic value)
EPS Correlation: 83.42 | EPS CAGR: 151.5% | SUE: 0.07 | # QB: 0
Revenue Correlation: 78.62 | Revenue CAGR: 44.93% | SUE: -0.45 | # QB: 0
EPS next Quarter (2026-06-30): EPS=4.46 | Chg7d=-0.035 | Chg30d=-0.304 | Revisions Net=-11 | Analysts=19
EPS current Year (2026-12-31): EPS=18.11 | Chg7d=+0.108 | Chg30d=+0.380 | Revisions Net=+21 | Growth EPS=+15.8% | Growth Revenue=+10.2%
EPS next Year (2027-12-31): EPS=20.73 | Chg7d=+0.116 | Chg30d=+0.361 | Revisions Net=+10 | Growth EPS=+14.4% | Growth Revenue=+7.4%
[Analyst] Revisions Ratio: -1.00 (0 Up / 11 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.8% (Discount Rate 11.8% - Earnings Yield 5.0%)
[Growth] Growth Spread = +0.9% (Analyst 7.7% - Implied 6.8%)